Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Vinmec Research Institute of Stem Cell and Gene Technology
With
Objectives: * Evaluate the frequency and severity of adverse events and serious adverse events (AEs/SAEs) of the therapy. * Evaluate the response rate after CD19 CAR T-cell infusion according to the following criteria: * Proportion of patients with complete response and partial response after CD19 CAR T-cell infusion * Progression-free survival (PFS) after infusion of CD19 CAR T-cells * Event-free survival (EFS) after infusion of CD19 CAR T-cells * Overall survival (OS) after infusion of CD19 CAR T-cells
Age
1–60
Sex
ALL
Healthy volunteers
Not accepted
